Arrakis Bio
PrivateLast Round
Seed
Jul 19, 2023
Company Overview
Arrakis Bio is a biotechnology company that is developing a technology to produce animal-free, high-quality human collagen and gelatin.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
RNA-targeted small moleculesrSMsdrug discovery platformRNA targetingdrugging RNAundruggable targetssmall molecule discoveryRNA therapeuticsPEARL-seqTRYSTbiopharma partnershipslicensing agreementsorally available medicinesoncologyneurology
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arrakis Bio Comps
Public and private peers based on sector, stage, and business model.
Arrakis Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 19, 2023 |
Key People
Founding team and executive leadership
Arrakis Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FLORA Ventures | Seed |
Arrakis Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arrakis Bio's valuation, stock price, and market status.
Firmographic Details
HeadquartersTel Aviv
Employee Range5
Year Founded2023
Last FundingJul 19, 2023
